NASDAQ · DRTS
Alpha Tau Medical Ltd
$13.23-$0.12 (-0.9%)
Alpha Tau Medical Ltd’s quoted price sits in the upper half of its reported 52-week range, 16.21% below the high.
Loading market information…
NASDAQ · IINN · USD
Stock price, earnings
Quote as of Aug 7, 2026, 01:30 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Inspira Technologies OXY B.H.N. Ltd.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Inspira Technologies OXY B.H.N. Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less. It also offers additive manufactured electronics platform that enables 3D architecture for systems operating in dilution cryostats. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:13 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| $0.00 |
| Q3 2023 | Nov 16, 2023 | -$0.22+26.67% vs estimate | $0.00 |
|---|
THE ANALYST VIEW
1 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$13.23-$0.12 (-0.9%)
Alpha Tau Medical Ltd’s quoted price sits in the upper half of its reported 52-week range, 16.21% below the high.
$13.51+$0.14 (+1.05%)
InMode Ltd.’s quoted price sits in the lower half of its reported 52-week range, 18.96% below the high.
$0.79-$0.01 (-1.38%)
Rapid Micro Biosystems, Inc.’s quoted price sits in the lower half of its reported 52-week range, 84.03% below the high.
$3.61+$0.24 (+7.12%)
HeartSciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 44.2% below the high.
$0.93+$0.05 (+5.09%)
Biofrontera Inc.’s quoted price sits in the lower half of its reported 52-week range, 43.89% below the high.
$0.44-$0.01 (-3.16%)
Ensysce Biosciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.36% below the high.
$0.79-$0.08 (-9.35%)
iSpecimen Inc.’s quoted price sits in the lower half of its reported 52-week range, 97.6% below the high.
$1.03$0.00 (0.0%)
ENvue Medical, Inc.’s quoted price sits in the lower half of its reported 52-week range, 82.78% below the high.
